Locus Cell Co., Ltd. (TPEX:6891)
29.45
+1.45 (5.18%)
At close: Nov 28, 2025
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 5.89 billion as of November 28, 2025. Its market cap has increased by 8.47% in one year.
Market Cap
5.89B
Enterprise Value
5.14B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.45
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 5.89B, a decrease of -40.38%. That is a compound annual growth rate of -13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 5.60B | 40.35% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 242.72B |
| PharmaEssentia | 186.40B |
| Lotus Pharmaceutical | 83.50B |
| Bora Pharmaceuticals Co., LTD. | 68.54B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.68B |
| Oneness Biotech | 31.13B |
| Center Laboratories | 27.25B |